US 6562347
Chemokine-tumor antigen fusion proteins as cancer vaccines
expired A61KA61K39/00
Quick answer
US patent 6562347 (Chemokine-tumor antigen fusion proteins as cancer vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K39/00